Haleon plc reports director’s share purchase

Published 13/05/2025, 13:14
Haleon plc reports director’s share purchase

Haleon plc (LSE/NYSE:HLN), a global consumer health company, disclosed a transaction by Marie-Anne Aymerich, an Independent (LON:IOG) Non-Executive Director and Person Discharging Managerial Responsibilities (PDMR), in a filing with the U.S. Securities and Exchange Commission today. Aymerich purchased 21,300 ordinary shares at a price of £4.051 each on May 9, 2025, as per the notification received by the company on May 13, 2025. The transaction took place on the London Stock Exchange (LON:LSEG).

This disclosure is in accordance with the UK Market Abuse Regulation, which mandates public notification of transactions by PDMRs. The transaction represents a single purchase of shares, with no aggregated transactions reported.

Haleon, known for its trusted brands such as Advil, Centrum, and Sensodyne, focuses on delivering everyday health products to consumers. The company’s portfolio covers major categories including Oral Health, Pain Relief, and Vitamins, Minerals, and Supplements (VMS), among others.

The information provided in this news article is based on Haleon plc’s recent SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.